AE37 peptide vaccination in prostate cancer: a 4-year immunological assessment updates on a phase I trial

dc.contributor.author	Gouttefangeas, Cécile	de_DE
dc.contributor.author	Kalbacher, Hubert	de_DE
dc.date.accessioned	2014-02-20T14:55:25Z
dc.date.available	2014-02-20T14:55:25Z
dc.date.issued	2013	de_DE
dc.identifier.issn	0340-7004	de_DE
dc.identifier.uri	http://hdl.handle.net/10900/41939
dc.language.iso	en	en
dc.publisher	Springer	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s00262-013-1461-3	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.subject.ddc	570	de_DE
dc.title	AE37 peptide vaccination in prostate cancer: a 4-year immunological assessment updates on a phase I trial	de_DE
dc.type	Article	de_DE
utue.quellen.id	20140116051827_00668	de_DE
utue.publikation.seiten	1599-1608	de_DE
utue.personen.roh	Perez, Sonia A.	de_DE
utue.personen.roh	Anastasopoulou, Eleftheria A.	de_DE
utue.personen.roh	Tzonis, Panagiotis	de_DE
utue.personen.roh	Gouttefangeas, Cecile	de_DE
utue.personen.roh	Kalbacher, Hubert	de_DE
utue.personen.roh	Papamichail, Michail	de_DE
utue.personen.roh	Baxevanis, Constantin N.	de_DE
dcterms.isPartOf.ZSTitelID	Cancer Immunology Immunotherapy	de_DE
dcterms.isPartOf.ZS-Issue	10	de_DE
dcterms.isPartOf.ZS-Volume	62	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE
utue.fakultaet	Sonstige	de_DE